Scientists test 'Living Drug' made from Patient's own cells to fight brain tumor
NCT ID NCT06254326
Summary
This early-stage study is testing a personalized treatment for adults whose oligodendroglioma, a type of brain tumor, has come back or gotten worse. Doctors will use a patient's own tumor and immune cells to create a custom vaccine and immune cell therapy, given alongside standard cancer drugs. The main goals are to see if this complex treatment can be reliably made and if it is safe for patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT OLIGODENDROGLIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Florida Health Shands Hospital
Gainesville, Florida, 32610, United States
Conditions
Explore the condition pages connected to this study.